EP2958486A4 - Vorrichtung zur ermöglichung von patientenselbsttests und behandlungsselbstverwaltung sowie system mit der vorrichtung für das management der gesundheitsversorgung eines patienten - Google Patents

Vorrichtung zur ermöglichung von patientenselbsttests und behandlungsselbstverwaltung sowie system mit der vorrichtung für das management der gesundheitsversorgung eines patienten

Info

Publication number
EP2958486A4
EP2958486A4 EP14753584.3A EP14753584A EP2958486A4 EP 2958486 A4 EP2958486 A4 EP 2958486A4 EP 14753584 A EP14753584 A EP 14753584A EP 2958486 A4 EP2958486 A4 EP 2958486A4
Authority
EP
European Patent Office
Prior art keywords
self
patient
managing
administration
testing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP14753584.3A
Other languages
English (en)
French (fr)
Other versions
EP2958486B1 (de
EP2958486A2 (de
Inventor
Rana J Arefieg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thuban Inc
Original Assignee
Thuban Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thuban Inc filed Critical Thuban Inc
Publication of EP2958486A2 publication Critical patent/EP2958486A2/de
Publication of EP2958486A4 publication Critical patent/EP2958486A4/de
Application granted granted Critical
Publication of EP2958486B1 publication Critical patent/EP2958486B1/de
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
    • A61B5/1405—Devices for taking blood samples
    • A61B5/1411—Devices for taking blood samples by percutaneous method, e.g. by lancet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A61B5/150022—Source of blood for capillary blood or interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150312—Sterilisation of piercing elements, piercing devices or sampling devices
    • A61B5/150328—Sterilisation of piercing elements, piercing devices or sampling devices by aseptic fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150358—Strips for collecting blood, e.g. absorbent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381—Design of piercing elements
    • A61B5/150412—Pointed piercing elements, e.g. needles, lancets for piercing the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381—Design of piercing elements
    • A61B5/150503—Single-ended needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150847—Communication to or from blood sampling device
    • A61B5/150854—Communication to or from blood sampling device long distance, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150954—Means for the detection of operative contact with patient, e.g. by temperature sensitive sensor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101—Details
    • A61B5/15103—Piercing procedure
    • A61B5/15107—Piercing being assisted by a triggering mechanism
    • A61B5/15113—Manually triggered, i.e. the triggering requires a deliberate action by the user such as pressing a drive button
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101—Details
    • A61B5/15115—Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
    • A61B5/15117—Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising biased elements, resilient elements or a spring, e.g. a helical spring, leaf spring, or elastic strap
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15186—Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
    • A61B5/15188—Constructional features of reusable driving devices
    • A61B5/1519—Constructional features of reusable driving devices comprising driving means, e.g. a spring, for propelling the piercing unit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02—Operational features
    • A61B2560/0266—Operational features for monitoring or limiting apparatus function
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/097—Devices for facilitating collection of breath or for directing breath into or through measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101—Details
    • A61B5/15115—Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
    • A61B5/15123—Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising magnets or solenoids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/27—General characteristics of the apparatus preventing use
    • A61M2205/276—General characteristics of the apparatus preventing use preventing unwanted use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/582—Means for facilitating use, e.g. by people with impaired vision by tactile feedback

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Dermatology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
EP14753584.3A 2013-02-22 2014-02-16 Behandlungsabgabeeinheit Not-in-force EP2958486B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/774,845 US9357961B2 (en) 2013-02-22 2013-02-22 Device for enabling patient self testing and treatment self- administration and system using the device for managing the patient's health care
PCT/US2014/016648 WO2014130376A2 (en) 2013-02-22 2014-02-16 Device for enabling patient self-testing and treatment self-administration and system using the device for managing the patient's health care

Publications (3)

Publication Number Publication Date
EP2958486A2 EP2958486A2 (de) 2015-12-30
EP2958486A4 true EP2958486A4 (de) 2016-11-30
EP2958486B1 EP2958486B1 (de) 2018-12-26

Family

ID=51388825

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14753584.3A Not-in-force EP2958486B1 (de) 2013-02-22 2014-02-16 Behandlungsabgabeeinheit

Country Status (4)

Country Link
US (2) US9357961B2 (de)
EP (1) EP2958486B1 (de)
JP (2) JP2016511669A (de)
WO (1) WO2014130376A2 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10318915B2 (en) 2012-09-26 2019-06-11 Thuban, Inc. Healthcare system for recording and monitoring transactions of system participants
US20150141871A1 (en) * 2013-09-24 2015-05-21 Kaveh Khast Pain minimizing injection system
US9594361B2 (en) 2013-10-15 2017-03-14 SILVAIR Sp. z o.o. Automation and control system with context awareness
US9542530B2 (en) * 2013-10-21 2017-01-10 Ims Health Incorporated System and method for multi-dimensional profiling of healthcare professionals
EP3167393B1 (de) * 2014-07-10 2019-11-06 Companion Medical Inc. Medikamentenverabreichungssystem mit injektionsstift und zugehöriger vorrichtung
WO2016145063A1 (en) * 2015-03-09 2016-09-15 Frick Roger L Inr control system and method
US20160374557A1 (en) * 2015-06-24 2016-12-29 Maryam Bakhshi Portable Health Monitoring System
US11596174B2 (en) 2015-10-06 2023-03-07 Gseh Holistic, Inc. Phyto material tablet, method and apparatus
US9907930B2 (en) * 2015-10-06 2018-03-06 Michael Alexander Trzecieski Aromatherapy vaporization device
JP6483334B1 (ja) * 2016-02-22 2019-03-13 ウエスト ファーマスーティカル サービシーズ インコーポレイテッド 医療デバイスのためのラベリング装置
EP3427393A1 (de) 2016-03-09 2019-01-16 Wavemark, Inc. Kommunikationssystem und verfahren für medizinischen schrank
US20170293035A1 (en) * 2016-04-07 2017-10-12 Surinder Badyal Wearable Lifetime Personal High Sensitivity and Wide-Dynamic Range Measurement Apparatus and Method for Real-Time Radiation Exposure Measurement and Cancer Risk Management Due to Harmful Radiation in All Environments
US10987032B2 (en) * 2016-10-05 2021-04-27 Cláudio Afonso Ambrósio Method, system, and apparatus for remotely controlling and monitoring an electronic device
US20180132781A1 (en) * 2016-11-15 2018-05-17 Homayemem Weli-Numbere Artery Locating Device and Automated Sampling Device for Arterial Blood Gas Measurement
US10625031B2 (en) * 2016-12-27 2020-04-21 L'oreal Orientation independent topical applicator
RU2019127652A (ru) * 2017-03-16 2021-04-16 Новартис Аг Устройство для инъекций
US11039765B2 (en) 2017-09-26 2021-06-22 International Business Machines Corporation Smart pellet for sample testing
US10610544B2 (en) 2017-11-03 2020-04-07 Lysulin, Inc. Insulin resistance and beta cell function using lysine-based supplements
US10653720B2 (en) 2017-11-03 2020-05-19 Lysulin, Inc. Prevention of protein glycation using lysine/zinc supplements
US10656166B2 (en) 2017-11-03 2020-05-19 Lysulin, Inc. Inhibiting chronic blood and nephrological disorders using lysine-based supplements
US11255838B2 (en) 2017-11-03 2022-02-22 Lysulin, Inc. Levels, functions, and resistances related to chronic conditions by using lysine-based supplements
WO2019157554A1 (en) * 2018-02-15 2019-08-22 Caretech Services Pty Ltd A platform and system for use in therapeutic procedures
EP4252816A3 (de) 2018-05-22 2024-01-17 C. R. Bard, Inc. Katheterisierungssystem und anwendungsverfahren dafür
JP7174778B2 (ja) 2018-06-06 2022-11-17 マシモ・コーポレイション オピオイド過剰摂取モニタリング
US20200405226A1 (en) * 2018-06-06 2020-12-31 Masimo Corporation Locating a locally stored medication
JP7314252B2 (ja) 2018-08-10 2023-07-25 シー・アール・バード・インコーポレーテッド 自動尿量測定システム
GB201814644D0 (en) 2018-09-10 2018-10-24 Hilton Eric Analysis and dispensing system
US11464410B2 (en) 2018-10-12 2022-10-11 Masimo Corporation Medical systems and methods
TWI694846B (zh) * 2019-09-18 2020-06-01 廣達電腦股份有限公司 注射筆的資訊收集裝置及其資訊收集方法
JP2022549330A (ja) 2019-09-25 2022-11-24 ヤンセン ファーマシューティカルズ，インコーポレーテッド 薬物投与システムの相互接続
US11730379B2 (en) 2020-03-20 2023-08-22 Masimo Corporation Remote patient management and monitoring systems and methods
CN111249012A (zh) * 2020-04-13 2020-06-09 康冰瑶 一种伸缩式儿科用体温监测护理装置
WO2021216596A1 (en) * 2020-04-22 2021-10-28 Cercacor Laboratories, Inc. Self-contained minimal action invasive blood constituent system
US20210379269A1 (en) * 2020-06-05 2021-12-09 C. R. Bard, Inc. Automated Fluid Output Monitoring
CN115867192A (zh) * 2020-06-26 2023-03-28 斯比拉切克有限公司 挥发性有机化合物捕获设备
CA204308S (en) * 2020-12-21 2023-08-21 Hoffmann La Roche Display screen with graphical user interface
US11931151B2 (en) 2020-12-22 2024-03-19 C. R. Bard, Inc. Automated urinary output measuring system
US20230181819A1 (en) * 2021-12-09 2023-06-15 Jubilee Biotech Co., Ltd. Medication compliance management system
CN116058922B (zh) * 2022-12-26 2024-04-30 上海心弘生命科学有限公司 一种超声辅助溶栓装置及系统
US11849379B1 (en) * 2023-05-31 2023-12-19 Pumaslife I Llc Universal mobile alert system and method

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226235A (en) 1979-01-25 1980-10-07 Survival Technology, Inc. Plural injecting device
US4329988A (en) 1980-12-23 1982-05-18 Survival Technology, Inc. Plural injection assembly
US4578064A (en) 1983-12-21 1986-03-25 Survival Technology Inc. Plural dosage automatic injector with improved safety
US4731726A (en) 1986-05-19 1988-03-15 Healthware Corporation Patient-operated glucose monitor and diabetes management system
EP0290683A3 (de) 1987-05-01 1988-12-14 Diva Medical Systems B.V. System und Vorrichtung zur medizinischen Behandlung der Zuckerkrankheit
US5956501A (en) 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
US5536249A (en) 1994-03-09 1996-07-16 Visionary Medical Products, Inc. Pen-type injector with a microprocessor and blood characteristic monitor
FI118509B (fi) 1996-02-12 2007-12-14 Nokia Oyj Menetelmä ja laitteisto potilaan veren glukoosipitoisuuden ennustamiseksi
US6021392A (en) 1996-12-09 2000-02-01 Pyxis Corporation System and method for drug management
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6302855B1 (en) 1998-05-20 2001-10-16 Novo Nordisk A/S Medical apparatus for use by a patient for medical self treatment of diabetes
DE69932844T2 (de) * 1998-11-30 2007-02-08 Novo Nordisk A/S Medizinische vorrichtung und verfahren der kontrolle der vorrichtung welche von einem patienten zur selbstbehandlung verwendet wird
US6192891B1 (en) 1999-04-26 2001-02-27 Becton Dickinson And Company Integrated system including medication delivery pen, blood monitoring device, and lancer
US6925393B1 (en) 1999-11-18 2005-08-02 Roche Diagnostics Gmbh System for the extrapolation of glucose concentration
US6996538B2 (en) 2000-03-07 2006-02-07 Unisone Corporation Inventory control system and methods
US20020016719A1 (en) * 2000-06-19 2002-02-07 Nemeth Louis G. Methods and systems for providing medical data to a third party in accordance with configurable distribution parameters
DE10061336A1 (de) 2000-12-08 2002-06-13 Roche Diagnostics Gmbh System zur Analyse von Probeflüssigkeiten beinhaltend eine Lagekontrolleinheit
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
US6875195B2 (en) 2001-09-19 2005-04-05 Soo Bong Choi Portable automatic insulin syringe device with blood sugar measuring function
US7404796B2 (en) 2004-03-01 2008-07-29 Becton Dickinson And Company System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
DE10332488A1 (de) * 2003-07-16 2005-02-24 Roche Diagnostics Gmbh Analysegerät und Analyseverfahren für Körperflüssigkeiten
US7591801B2 (en) * 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
SI1656170T1 (sl) 2003-08-12 2019-05-31 Eli Lilly And Company Oprema za izdajanje zdravil s trojnim vijačnim navojem za mehanski pospešek
JP2005112499A (ja) 2003-10-03 2005-04-28 Hitachi Ltd 物品残量在庫管理発注システムおよびそれを用いた物品受発注管理システム
CA2767916C (en) 2004-02-18 2014-04-15 Ares Trading S.A. Hand-held electronically controlled injection device for injecting liquid medications
JP4549079B2 (ja) * 2004-03-05 2010-09-22 パナソニック株式会社 医療用投与器具
ES2772853T3 (es) 2004-04-30 2020-07-08 Becton Dickinson Co Sistemas y procedimientos para administrar un régimen médico
US7727147B1 (en) 2004-05-14 2010-06-01 Flint Hills Scientific Llc Method and system for implantable glucose monitoring and control of a glycemic state of a subject
TW200622953A (en) * 2004-12-21 2006-07-01 Mitac Technology Corp Life-sign detecting and real-time reporting module
US8361026B2 (en) 2005-02-01 2013-01-29 Intelliject, Inc. Apparatus and methods for self-administration of vaccines and other medicaments
US7547281B2 (en) 2005-02-01 2009-06-16 Medtronic Minimed, Inc. Algorithm sensor augmented bolus estimator for semi-closed loop infusion system
US7639136B1 (en) 2005-05-13 2009-12-29 WaveMark, Inc. RFID medical supplies consumption monitoring system and method
US8202249B2 (en) * 2005-09-20 2012-06-19 Panasonic Corporation Injection device with puncture function, method for controlling injection device with puncture function, chemical solution administration device, and method for controlling chemical solution administration device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8044778B2 (en) 2007-07-12 2011-10-25 Henry Schein, Inc. Injection device and case with reporting ability
US7752085B2 (en) 2006-07-13 2010-07-06 Henry Schein, Inc. Product information management system
US20080119705A1 (en) 2006-11-17 2008-05-22 Medtronic Minimed, Inc. Systems and Methods for Diabetes Management Using Consumer Electronic Devices
US7737858B2 (en) 2007-03-21 2010-06-15 Logitag Systems Ltd. System, method and kit for managing inventory
US20080269673A1 (en) 2007-04-27 2008-10-30 Animas Corporation Cellular-Enabled Medical Monitoring and Infusion System
US20090138207A1 (en) 2007-05-24 2009-05-28 Cosentino Daniel L Glucose meter system and monitor
US20080300572A1 (en) 2007-06-01 2008-12-04 Medtronic Minimed, Inc. Wireless monitor for a personal medical device system
US20080306434A1 (en) 2007-06-08 2008-12-11 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
CN101795624B (zh) 2007-08-29 2012-09-12 百瑞特公司 包括采样装置、确定装置和注射装置的便携式医疗设备
JP2011504129A (ja) 2007-11-21 2011-02-03 メディンゴ・リミテッド アナライト監視及び流体分注システム
GB2446247B (en) 2007-11-27 2008-12-17 Robert Joseph Wagener Homeostatic insulin pump
CA2731031A1 (en) 2008-07-18 2010-01-21 Lifescan, Inc. Analyte measurement and management device and associated methods
WO2010042849A1 (en) 2008-10-09 2010-04-15 Solstice Medical, Llc System and method for inventory management of medical assets
US8366682B2 (en) 2009-03-04 2013-02-05 Washington Biotech Corporation Medicine injection apparatuses
US20120173287A1 (en) 2009-08-31 2012-07-05 Nelson Parker Cowand Medical Compliance Kiosk
US20110082711A1 (en) 2009-10-06 2011-04-07 Masimo Laboratories, Inc. Personal digital assistant or organizer for monitoring glucose levels
AU2011203422B2 (en) 2009-12-30 2015-07-16 Tranquility Group Pty Ltd Method and apparatus for accurate and secure product dispensing
US8828330B2 (en) 2010-01-28 2014-09-09 Abbott Diabetes Care Inc. Universal test strip port
US9336353B2 (en) 2010-06-25 2016-05-10 Dexcom, Inc. Systems and methods for communicating sensor data between communication devices of a glucose monitoring system
US8206340B2 (en) 2010-08-18 2012-06-26 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification
US20120047049A1 (en) 2010-08-20 2012-02-23 Jarrett Cadiz System and method for provisioning pharmaceutical inventory
US20120203566A1 (en) 2010-12-23 2012-08-09 Stratice Llc System and method for providing electronic orders for medical equipment
US20120330119A1 (en) * 2011-06-21 2012-12-27 Gadlight, Inc. Analyte Testing Device with Lancet Cartridge and Test Strip Cartridge
US9849252B2 (en) * 2012-05-04 2017-12-26 Sofia Eleni Armes Electromechanical manipulating device for medical needle and syringe with sensory biofeedback and pain suppression capability

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
US20140243635A1 (en) 2014-08-28
WO2014130376A3 (en) 2015-05-14
US20160263317A1 (en) 2016-09-15
WO2014130376A2 (en) 2014-08-28
EP2958486B1 (de) 2018-12-26
EP2958486A2 (de) 2015-12-30
JP2018183598A (ja) 2018-11-22
JP2016511669A (ja) 2016-04-21
US9357961B2 (en) 2016-06-07

Similar Documents

Publication Publication Date Title
EP2958486A4 (de) Vorrichtung zur ermöglichung von patientenselbsttests und behandlungsselbstverwaltung sowie system mit der vorrichtung für das management der gesundheitsversorgung eines patienten
PT2999392T (pt) Sistema e método de imagiologia de uma parte do corpo de um utilizador paciente
HK1213192A1 (zh) 用於在人類受試者中治療眼部疾病的方法和裝置
HK1223246A1 (zh) 疼痛藥物組合及其用途
IL245349A0 (en) Patient control system
HK1215656A1 (zh) 旨在用於角膜的長期存儲或對人或動物角膜的活體外實驗的醫療設備
PL2870913T3 (pl) Urządzenie do pobierania, przechowywania i/albo obróbki krwi lub innych substancji pochodzenia ludzkiego lub zwierzęcego, i do stosowania preparatów krwiopochodnych lub innych preparatów biologicznych
WO2014186453A3 (en) Apparatus and method for administering a medical device prescription
EP2994876A4 (de) Systeme und vorrichtungen zur verabreichung von gesundheitsfürsorgesystemen
GB201314512D0 (en) Dual Haemodialysis and Haemodiafiltration blood treatment device
EP2958506A4 (de) Haltevorrichtung für chirurgisches werkzeug, endoskop und medizinisches system
EP3052044A4 (de) Patientengesteuerte zahnärztliche vorrichtung und verfahren
HK1208830A1 (en) Drug delivery device for the treatment of patients with respiratory diseases
IL233557A0 (en) Use of lequinimod for the treatment of Crohn's disease in which the anti-TN-AP alpha treatment has failed
IL245738A0 (en) Oxindole derivatives, ways of their preparation and their therapeutic use in the treatment of ampk-related diseases
ZA201508526B (en) Use of chinese medicine preparation in preparing drug for preventing and/or treating chrohn's disease
PL3054837T3 (pl) Urządzenie do bezdotykowego monitorowania czynności życiowych pacjenta
EP2949651A4 (de) Substituierte benzothiazole und therapeutische verwendungen davon zur behandlung von erkrankungen des menschen
IL258835B (en) A medical device for tissue sensing and/or stimulation
BR112016009538A2 (pt) Dispositivo médico para uso com um material de preenchimento líquido e para ocupar um espaço dentro do corpo de um paciente
LT2774991T (lt) Vaisto įvedimo sistema, skirta naudoti neurologinių sutrikimų gydymui arba diagnostikai
EP3067092A4 (de) Medizinisches instrument und lichtstrahlen-behandlungsvorrichtung
GB2499687B (en) Medical device for the treatment of a patient
EP2902806A4 (de) Nuklearmedizinische diagnostische vorrichtung und vorrichtung zur verarbeitung von medizinischen daten
EP2985024A4 (de) Therapeutikum für systemische knochenerkrankungen und verwendung davon

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150922

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602014038652

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61B0005000000

Ipc: A61B0005157000

A4 Supplementary search report drawn up and despatched

Effective date: 20161028

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/151 20060101ALI20161024BHEP

Ipc: A61M 5/172 20060101ALI20161024BHEP

Ipc: A61B 5/15 20060101ALI20161024BHEP

Ipc: A61B 5/00 20060101ALI20161024BHEP

Ipc: A61B 5/157 20060101AFI20161024BHEP

Ipc: A61B 5/145 20060101ALI20161024BHEP

Ipc: A61B 5/097 20060101ALI20161024BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20171207

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20180724

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1080296

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190115

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602014038652

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: E. BLUM AND CO. AG PATENT- UND MARKENANWAELTE , CH

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190326

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190326

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20181226

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190327

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1080296

Country of ref document: AT

Kind code of ref document: T

Effective date: 20181226

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190426

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190426

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602014038652

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190216

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20190228

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

26N No opposition filed

Effective date: 20190927

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190216

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20200226

Year of fee payment: 7

Ref country code: GB

Payment date: 20200225

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20200224

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190216

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20200219

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20140216

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602014038652

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20210216

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210228

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210216

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210228

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226